Eli Lilly Corp. buy Sanford C. Bernstein
Start price
17.10.24
/
50%
€852.00
Target price
17.10.25
€1,014.1
Performance (%)
-19.44%
End price
18.10.25
€686.40
Summary
This prediction ended on 18.10.25 with a price of €686.40. The price of Eli Lilly Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.44%. Sanford_C__Bernstein has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €2.66 are taken into consideration when calculating the performance. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -0.835% | -0.835% | 17.100% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,100.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten